March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
Former City of Hope Patient Inspires Others Facing Childhood Cancer
February 6, 2018 | Robin Heffler
It’s been more than 25 years, but the Tadros family still remembers the anxiety of learning that then 3-year-old Bishoy had acute lymphoblastic leukemia (ALL), the most common type of childhood cancer. But they also remember the hope they mustered from within and from the medical care he received thousands of miles away.
George Winston, Celebrated Composer, Writes Latest Album while Recuperating at City of Hope
January 11, 2018 | Michael Easterling
Celebrated acoustic solo pianist George Winston spent most of the first quarter of 2013 at City of Hope, recuperating after receiving a lifesaving bone marrow transplant. There, he wrote his latest album, "Spring Carousel."
‘We’re Like a Family’: Meet Platelet Donor Lorna Badame
December 20, 2017 | Maxine Nunes
Lorna Badame would probably be the last person to tell you she’s extraordinary, but what else would you call a woman who — over the last quarter of a century — has made more than 420 platelet donations to City of Hope.
Researchers discover sugar-addiction of cancer cells in childhood leukemia
July 10, 2017 | Katie Neith
According to a new article in Nature, a team led by City of Hope’s Markus Müschen, M.D., Ph.D., Chair of the Department of Systems Biology, thinks that sugar uptake and energy supply may play a key role in the relapse of ALL.
The Search for the Elephant Gene
July 5, 2017 | Michael Easterling
The African bull elephant is the largest mammal on the planet, comprised of trillions of cells that should ostensibly be a breeding ground for cancer. But because of an evolutionary anomaly, elephants don’t get cancer, a fact that fascinates Markus Müschen, M.D., Ph.D.
City of Hope Physicians and Scientists Present Trailblazing Research at Annual ASCO Meeting
June 2, 2017 | Letisia Marquez
City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.
New Mom Finds Fresh Outlook After Surviving Rare Hybrid Leukemia
May 12, 2017 | Samantha Bonar
Nine months after her daughter’s birth, Monica Weld got a bad sore throat and cough that she just couldn’t shake. She and her husband went directly to the hospital, where tests showed she had not one, but two kinds of leukemia: acute lymphoblastic (ALL) and acute myeloid (AML).
Markus Müschen, M.D., Ph.D., Is a Man on a Mission: Ending Childhood Leukemia
February 14, 2017 | Abe Rosenberg
Hailed as one of the best researchers of his generation, Markus Müschen, M.D., Ph.D., has joined City of Hope with the singular goal of wiping out Acute Lymphoblastic Leukemia (ALL), the most common form of cancer in children.
After Surviving Acute Lymphoblastic Leukemia, Ivan Garcia-Burgos is Paying it Forward
September 15, 2016 | Michael Easterling
Ivan Garcia-Burgos was a typical 21-year-old: hanging out with friends, working on his beloved sports car and playing team volleyball. Yet at a time in life that should be about hope for the future, Ivan had to confront the cold reality that he may not have one - he was diagnosed with Acute Lymphoblastic Leukemia.
Cancer Insights: The potential of CAR T cells to fight prostate cancer
March 2, 2015 | Sumanta Kumar Pal M.D.
Pick up any biotech industry report and you’re guaranteed to come across one term repeatedly – CAR T therapy. A fierce competition is now underway to bring CAR T treatments to market – several companies (Juno, Novartis, Kite and Cellectis, to name a few) have major stakes in the race.